BCBA/AZND (BCBA/AZND)

Buenos Aires Stock Exchange: BCBA/AZND · USD

$45.4

-0.39 (-0.8%)· Recorded snapshot

Market cap	406.6T
Revenue (ttm)	90.9T
Net income (ttm)	15.5T
EPS (ttm)	$2,729
P/E (trailing)	25.6x
P/E (forward)	15.8x
Dividend	$1,075 (1.54%)
Volume	4

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 90.9T
Net income (ttm): 15.5T
EPS (ttm): $2,729
P/E (trailing): 25.6x
P/E (forward): 15.8x
Market cap: 406.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E15.8

P25 n/aP50 n/aP75 n/a

Trailing P/E25.6

P25 n/aP50 n/aP75 n/a

ROE22

P25 n/aP50 n/aP75 n/a

ROIC16.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BCBA/AZND indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United Kingdom
Country code	AR
Earnings date	2026-10-30
Employees	96,100
Employees change	1,800
Employees growth	1.91%
Enterprise value	$449T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-18
Fiscal year end	December
Founded	1992
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112489
Last earnings date	2026-07-27
Last refreshed	2026-10-28
Market cap	$406.6T
Next earnings date	2026-10-30
Price	$45.42
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/AZND
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	84.65x
Average P/E ratio (3Y)	30.99x
Average P/E ratio (5Y)	130.79x
Earnings yield	3.91%
EV/Earnings	29.04x
EV/EBIT	19.46x
EV/EBITDA	14.11x
EV/FCF	28.44x
EV/Sales	4.75x
FCF / EV yield	3.52%
FCF yield	3.88%
Forward P/E	15.78x
Graham number	17.9861
Graham upside	-60.4%
Lynch fair value	$39.03
Lynch upside	-14.07%
P/(FCF - SBC) ratio	26.67x
P/(OCF - SBC) ratio	20.61x
P/B ratio	5.45x
P/E ratio	25.57x
P/FCF ratio	25.76x
P/OCF ratio	20.06x
P/S ratio	4.48x
Price/EBITDA ratio	13.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.42%
EBITDA margin	33%
Effective tax rate	16.95%
FCF margin	16.76%
Gross margin	81.69%
Operating margin	24.42%
Pretax margin	20.51%
Profit margin	17.02%
Profit per employee	$161M
Profitable quarters	18
Profitable years	36
Revenue per employee	$946M
ROA	8.21%
ROA (5Y)	5.95%
ROCE	17.78%
ROE	21.96%
ROE (5Y)	13.03%
ROIC	16.43%
ROIC (5Y)	13.29%
SBC / revenue	0.6%
Tax / revenue	3.48%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.84%
EPS growth (Q)	2.55%
EPS growth (QoQ)	-18.27%
EPS growth 10Y	14.33%
EPS growth 3Y	19.13%
EPS growth 5Y	18.4%
EPS growth years	4
FCF growth	-4.55%
FCF growth (Q)	-22.92%
FCF growth (QoQ)	-25.25%
FCF growth 3Y	5.66%
FCF growth 5Y	14.81%
Gross profit growth	7.69%
Gross profit growth (Q)	7.25%
Gross profit growth 3Y	9.19%
Gross profit growth 5Y	17.24%
Net income growth	25.93%
Net income growth (Q)	2.33%
Net income growth (QoQ)	-18.6%
Net income growth 3Y	19.23%
Net income growth 5Y	22.6%
Net income growth years	4
OCF growth	2.32%
OCF growth (Q)	-15.39%
OCF growth (QoQ)	-14.71%
OCF growth 10Y	14.02%
OCF growth 3Y	10.41%
OCF growth 5Y	16.27%
Operating income growth	5.8%
Operating income growth (Q)	2.88%
Operating income growth 3Y	9.95%
Operating income growth 5Y	31.31%
Revenue growth	8.61%
Revenue growth (Q)	6.41%
Revenue growth (QoQ)	0.63%
Revenue growth 10Y	9.81%
Revenue growth 3Y	11.32%
Revenue growth 5Y	15.75%
Revenue growth quarters	13
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-4.5T
Depreciation and amortization	$8.1T
EBIT	$22.2T
EBITDA	$30T
EPS	$2,728.76
Financing cash flow	$-11.4T
Free cash flow	$15.8T
Free cash flow minus SBC	$15.3T
Gross profit	$74.3T
Income taxes	$3.2T
Investing cash flow	$-12.1T
Net borrowing	$-2.9T
Net cash flow	$-3.2T
Net income	$15.5T
Operating cash flow minus SBC	$19.8T
Operating income	$22.2T
Revenue	$90.9T
Stock-based compensation	$542.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.58
Book value per share	$48,041.29
Debt / EBITDA	1.57
Debt / equity	0.64
Debt / FCF	3.03
Goodwill	$32.5T
Interest coverage	10.64
Long-term assets	$128.6T
Long-term liabilities	$48.5T
Net cash (debt)	$-40.6T
Net cash / market cap	-9.97%
Net debt / EBITDA	1.35
Net debt / equity	0.54
Net debt / FCF	2.57
Piotroski F-Score	7
Property, plant and equipment	$25T
Shareholders' equity	$74.6T
Tangible book value	$-12.8T
Tangible book value per share	$-8,223.23
Total assets	$171.6T
Total cash	$7.4T
Total debt	$47.9T
Total liabilities	$97T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	$43T
Current liabilities	$48.5T
Current ratio	0.89
Inventory turnover	1.68
Net working capital	$-3.3T
Quick ratio	0.66
Working capital	$-5.3T
Working capital turnover	-22,214.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.03%
Dividend growth	5.21%
Dividend growth (3Y)	4.38%
Dividend growth years	3
Dividend payment date	2026-09-08
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	$1,075.42
Dividend yield	1.54%
Ex-dividend date	2026-08-07
Last dividend	$0.24
Payout ratio	45.73%
Shareholder yield	1.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$46.02
1D price change	-0.85%
1M price change	4.13%
1M total return	4.13%
1W price change	4.46%
1W total return	4.46%
1Y price change	9%
1Y return CAGR	10.77%
1Y total return	10.77%
20-day SMA	$43.11
200-day SMA	$45.21
3M price change	2.69%
3M total return	3.35%
3Y price change	27.94%
3Y return CAGR	10.51%
3Y total return	34.95%
50-day SMA	$42.81
50-day SMA vs 200-day SMA	50under200
52-week high	$53.80
52-week high date	2026-02-27
52-week low	$39.97
52-week low date	2026-08-03
5Y price change	51.4%
5Y return CAGR	10.34%
5Y total return	63.52%
6M price change	-7.34%
6M total return	-6.75%
All-time high	$53.80
All-time high date	2026-02-24
All-time low	$28.00
All-time low date	2021-08-11
Average true range (ATR)	$0.77
Average volume	53
Change from 52-week high	-15.58%
Change from 52-week low	13.64%
Change from all-time high	-15.58%
Change from all-time low	62.21%
Change from open	0%
Day's gap	-0.85%
Dollar volume	$182
High price	$45.42
Low price	$45.42
Monthly RSI	54.18
Open price	$45.42
Previous close	$45.81
Price vs 150-day SMA	-1.31%
Price vs 20-day SMA	5.36%
Price vs 200-day SMA	0.46%
Price vs 50-day SMA	6.09%
Relative volume	0.08
RSI	60.92
Sharpe ratio	0.8
Sortino ratio	1.36
Volume	4
Weekly RSI	53.36
YTD price change	-9.16%
YTD total return	-7.69%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.5B
Shares change (QoQ)	-0.06%
Shares change (YoY)	-0.03%
Shares held by insiders	0.04%
Shares held by institutions	74.28%

Deeper analysis on BCBA/AZND

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BCBA/AZND report

Is a complete BCBA/AZND research report available?

No complete published report is available for bcba/AZND (BCBA/AZND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

406.6T

Revenue (ttm)

90.9T

Net income (ttm)

15.5T

EPS (ttm)

$2,729

P/E (trailing)

25.6x

P/E (forward)

15.8x

Dividend

$1,075 (1.54%)

Volume

Metric

Value

Amount currency

ARS

Country

United Kingdom

Country code

Earnings date

2026-10-30

Employees

96,100

Employees change

1,800

Employees growth

1.91%

Enterprise value

$449T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-07-18

Fiscal year end

December

Founded

1992

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT112489

Last earnings date

2026-07-27

Last refreshed

2026-10-28

Market cap

$406.6T

Next earnings date

2026-10-30

Price

$45.42

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

bcba/AZND

Website

https://www.astrazeneca.com

Metric

Value

Average P/E ratio (10Y)

84.65x

Average P/E ratio (3Y)

30.99x

Average P/E ratio (5Y)

130.79x

Earnings yield

3.91%

EV/Earnings

29.04x

EV/EBIT

19.46x

EV/EBITDA

14.11x

EV/FCF

28.44x

EV/Sales

4.75x

FCF / EV yield

3.52%

FCF yield

3.88%

Forward P/E

15.78x

Graham number

17.9861

Graham upside

-60.4%

Lynch fair value

$39.03

Lynch upside

-14.07%

P/(FCF - SBC) ratio

26.67x

P/(OCF - SBC) ratio

20.61x

P/B ratio

5.45x

P/E ratio

25.57x

P/FCF ratio

25.76x

P/OCF ratio

20.06x

P/S ratio

4.48x

Price/EBITDA ratio

13.57x

Metric

Value

EBIT margin

24.42%

EBITDA margin

33%

Effective tax rate

16.95%

FCF margin

16.76%

Gross margin

81.69%

Operating margin

24.42%

Pretax margin

20.51%

Profit margin

17.02%

Profit per employee

$161M

Profitable quarters

Profitable years

Revenue per employee

$946M

ROA

8.21%

ROA (5Y)

5.95%

ROCE

17.78%

ROE

21.96%

ROE (5Y)

13.03%

ROIC

16.43%

ROIC (5Y)

13.29%

SBC / revenue

0.6%

Tax / revenue

3.48%

Metric

Value

EPS growth

25.84%

EPS growth (Q)

2.55%

EPS growth (QoQ)

-18.27%

EPS growth 10Y

14.33%

EPS growth 3Y

19.13%

EPS growth 5Y

18.4%

EPS growth years

FCF growth

-4.55%

FCF growth (Q)

-22.92%

FCF growth (QoQ)

-25.25%

FCF growth 3Y

5.66%

FCF growth 5Y

14.81%

Gross profit growth

7.69%

Gross profit growth (Q)

7.25%

Gross profit growth 3Y

9.19%

Gross profit growth 5Y

17.24%

Net income growth

25.93%

Net income growth (Q)

2.33%

Net income growth (QoQ)

-18.6%

Net income growth 3Y

19.23%

Net income growth 5Y

22.6%

Net income growth years

OCF growth

2.32%

OCF growth (Q)

-15.39%

OCF growth (QoQ)

-14.71%

OCF growth 10Y

14.02%

OCF growth 3Y

10.41%

OCF growth 5Y

16.27%

Operating income growth

5.8%

Operating income growth (Q)

2.88%

Operating income growth 3Y

9.95%

Operating income growth 5Y

31.31%

Revenue growth

8.61%

Revenue growth (Q)

6.41%

Revenue growth (QoQ)

0.63%

Revenue growth 10Y

9.81%

Revenue growth 3Y

11.32%

Revenue growth 5Y

15.75%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

$-4.5T

Depreciation and amortization

$8.1T

EBIT

$22.2T

EBITDA

$30T

EPS

$2,728.76

Financing cash flow

$-11.4T

Free cash flow

$15.8T

Free cash flow minus SBC

$15.3T

Gross profit

$74.3T

Income taxes

$3.2T

Investing cash flow

$-12.1T

Net borrowing

$-2.9T

Net cash flow

$-3.2T

Net income

$15.5T

Operating cash flow minus SBC

$19.8T

Operating income

$22.2T

Revenue

$90.9T

Stock-based compensation

$542.2B

Metric

Value

Altman Z-Score

3.58

Book value per share

$48,041.29

Debt / EBITDA

1.57

Debt / equity

0.64

Debt / FCF

3.03

Goodwill

$32.5T

Interest coverage

10.64

Long-term assets

$128.6T

Long-term liabilities

$48.5T

Net cash (debt)

$-40.6T

Net cash / market cap

-9.97%

Net debt / EBITDA

1.35

Net debt / equity

0.54

Net debt / FCF

2.57

Piotroski F-Score

Property, plant and equipment

$25T

Shareholders' equity

$74.6T

Tangible book value

$-12.8T

Tangible book value per share

$-8,223.23

Total assets

$171.6T

Total cash

$7.4T

Total debt

$47.9T

Total liabilities

$97T

Metric

Value

Asset turnover

0.54

Current assets

$43T

Current liabilities

$48.5T

Current ratio

0.89

Inventory turnover

1.68

Net working capital

$-3.3T

Quick ratio

0.66

Working capital

$-5.3T

Working capital turnover

-22,214.72

Metric

Value

Buyback yield / dilution

0.03%

Dividend growth

5.21%

Dividend growth (3Y)

4.38%

Dividend growth years

Dividend payment date

2026-09-08

Dividend payment years

Dividend payout frequency

Semi-Annual

Dividend per share

$1,075.42

Dividend yield

1.54%

Ex-dividend date

2026-08-07

Last dividend

$0.24

Payout ratio

45.73%

Shareholder yield

1.57%

Metric

Value

150-day SMA

$46.02

1D price change

-0.85%

1M price change

4.13%

1M total return

4.13%

1W price change

4.46%

1W total return

4.46%

1Y price change

1Y return CAGR

10.77%

1Y total return

10.77%

20-day SMA

$43.11

200-day SMA

$45.21

3M price change

2.69%

3M total return

3.35%

3Y price change

27.94%

3Y return CAGR

10.51%

3Y total return

34.95%

50-day SMA

$42.81

50-day SMA vs 200-day SMA

50under200

52-week high

$53.80

52-week high date

2026-02-27

52-week low

$39.97

52-week low date

2026-08-03

5Y price change

51.4%

5Y return CAGR

10.34%

5Y total return

63.52%

6M price change

-7.34%

6M total return

-6.75%

All-time high

$53.80

All-time high date

2026-02-24

All-time low

$28.00

All-time low date

2021-08-11

Average true range (ATR)

$0.77

Average volume

Change from 52-week high

-15.58%

Change from 52-week low

13.64%

Change from all-time high

-15.58%

Change from all-time low

62.21%

Change from open

Day's gap

-0.85%

Dollar volume

$182

High price

$45.42

Low price

$45.42

Monthly RSI

54.18

Open price

$45.42

Previous close

$45.81

Price vs 150-day SMA

-1.31%

Price vs 20-day SMA

5.36%

Price vs 200-day SMA

0.46%

Price vs 50-day SMA

6.09%

Relative volume

0.08

RSI

60.92

Sharpe ratio

0.8

Sortino ratio

1.36

Volume

Weekly RSI

53.36

YTD price change

-9.16%

YTD total return

-7.69%

Metric

Value

Float

1.5B

Shares change (QoQ)

-0.06%

Shares change (YoY)

-0.03%

Shares held by insiders

0.04%

Shares held by institutions

74.28%

BCBA/AZND (BCBA/AZND)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AZND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AZND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/AZND

Frequently asked questions

BCBA/AZND (BCBA/AZND)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AZND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AZND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/AZND

Frequently asked questions